Literature DB >> 32584215

Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in Acinetobacter baumannii complex bacteraemia: experience from the Chinese Antimicrobial Resistance Surveillance of Nosocomial Infections (CARES) Network.

Yudong Liu1, Qi Wang1, Chunjiang Zhao1, Hongbin Chen1, Henan Li1, Hui Wang1, On Behalf Of The Cares Network.   

Abstract

Introduction. Increasing evidence demonstrates unfavourable outcomes in bloodstream infections (BSI) due to the carbapenem-resistant Acinetobacter baumannii complex (CRAB).Aim. To investigate the differences in risk factors, clinical characteristics and outcomes in patients with A. baumannii complex BSI stratified by carbapenem resistance, a prospective multi-center study was conducted.Methodology. Information was collected in a predefined form. A total of 317 cases was included for comparison between CRAB BSI vs. carbapenem-susceptible A. baumannii complex (CSAB) BSI. Among these cases, 229 cases were defined as CRAB BSI and 88 cases as CSAB BSI.Results. Univariable analysis showed that male gender, underlying neurologic disease, prior carbapenems exposure, intensive care unit (ICU) stay, presence of central venous catheter, endotracheal intubation, tracheotomy, Foley catheter, nasogastric intubation, lower respiratory tract infections and catheter-related infections were more prevalent in CRAB BSI. Only male gender, prior carbapenems exposure and presence of endotracheal intubation persisted as independent risk factors for acquiring CRAB BSI. Patients with CRAB BSI displayed unfavourable outcomes characterized by failure of pathogen clearance, continuous fever, disease aggravation and higher incidence of 30-day all-cause mortality. Multivariate analysis demonstrated carbapenem resistance as an independent risk factor for 30-day all-cause mortality.Conclusion. Our findings reveal the epidemiological differences between CRAB BSI and CSAB BSI in a Chinese cohort. Our data suggest that carbapenem resistance has a significant impact on mortality for patients with A. baumannii complex BSI, further strengthening the importance of active prevention and control strategies for the spread of CRAB in Chinese hospitals.

Entities:  

Keywords:  Carbapenem-resistant A. baumannii; bloodstream infections; clinical characteristics; outcomes; risk factors

Year:  2020        PMID: 32584215     DOI: 10.1099/jmm.0.001222

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

1.  Surveillance of Multidrug-Resistant Bacterial Infections in Non-Adult Patients - Zhejiang Province, China, 2014-2019.

Authors:  Yuchen Wu; Shi Chen; Jiaping Li; Chang Cai; Hanyu Wang; Mingming Zhou; Junmin Cao; Qiang Wang; Shenghai Wu; Shibiao Ding; Xiaofei Zhao; Long Sun; Qingfeng Hu; Hongwei Zhou; Xiang Qian; Qing Yang; Sheng Chen; Rong Zhang
Journal:  China CDC Wkly       Date:  2021-11-19

2.  Evolution of Acinetobacter baumannii in Clinical Bacteremia Patients.

Authors:  Henan Li; Jiangang Zhang; Zhiren Wang; Yuyao Yin; Hua Gao; Ruobing Wang; Longyang Jin; Qi Wang; Chunjiang Zhao; Zhanwei Wang; Hui Wang
Journal:  Infect Drug Resist       Date:  2021-08-31       Impact factor: 4.003

Review 3.  Adverse clinical outcomes associated with carbapenem-resistant Acinetobacter (CRA) infections: a systematic review and meta-analysis.

Authors:  Weiping Ling; Luis Furuya-Kanamori; Yukiko Ezure; Patrick N A Harris; David L Paterson
Journal:  JAC Antimicrob Resist       Date:  2021-11-05

4.  Multicenter Study of the Risk Factors and Outcomes of Bloodstream Infections Caused by Carbapenem-Non-Susceptible Acinetobacter baumannii in Indonesia.

Authors:  Dewi Anggraini; Dewi Santosaningsih; Pepy Dwi Endraswari; Novira Jasmin; Fajri Marindra Siregar; Usman Hadi; Kuntaman Kuntaman
Journal:  Trop Med Infect Dis       Date:  2022-07-31

5.  The Burden of Carbapenem-Resistant Acinetobacter baumannii in ICU COVID-19 Patients: A Regional Experience.

Authors:  Giorgia Montrucchio; Silvia Corcione; Tommaso Lupia; Nour Shbaklo; Carlo Olivieri; Miriam Poggioli; Aline Pagni; Davide Colombo; Agostino Roasio; Stefano Bosso; Fabrizio Racca; Valeria Bonato; Francesco Della Corte; Stefania Guido; Andrea Della Selva; Enrico Ravera; Nicoletta Barzaghi; Martina Cerrano; Pietro Caironi; Giacomo Berta; Cecilia Casalini; Bruno Scapino; Michele Grio; Massimiliano Parlanti Garbero; Gabriella Buono; Federico Finessi; Simona Erbetta; Paola Federica Sciacca; Gilberto Fiore; Alessandro Cerutti; Sergio Livigni; Daniela Silengo; Fulvio Agostini; Maurizio Berardino; Mauro Navarra; Silvia Vendramin; Enzo Castenetto; Marco Maria Liccardi; Emilpaolo Manno; Luca Brazzi; Francesco Giuseppe De Rosa
Journal:  J Clin Med       Date:  2022-09-02       Impact factor: 4.964

6.  Clinical Profile, Prognostic Factors, and Outcome Prediction in Hospitalized Patients With Bloodstream Infection: Results From a 10-Year Prospective Multicenter Study.

Authors:  Longyang Jin; Chunjiang Zhao; Henan Li; Ruobing Wang; Qi Wang; Hui Wang
Journal:  Front Med (Lausanne)       Date:  2021-05-20

7.  Microbial Distribution and Antibiotic Susceptibility of Bloodstream Infections in Different Intensive Care Units.

Authors:  Nan Duan; Liying Sun; Chenwei Huang; Haixia Li; Bin Cheng
Journal:  Front Microbiol       Date:  2021-12-09       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.